Sagimet Biosciences Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Sagimet Biosciences granted an aggregate of 260,700 stock options to three newly hired employees as an inducement material to their acceptance of employment. The options have a ten-year term, vest over four years, and carry an exercise price equal to the closing market price on August 17, 2026.
Key figures
- Options granted
- 260700
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.